Kevin F Haas, MD
Disclosures: Contracted Research-Neuropace-Site PI for FDA mandated post-approval study which has 1% of my effort associated.-Neuropace responsive neurostimulator-Medication-resistant epilepsy-Option_2-Option_2-Will be discussed in some cases as a potential treatment option for medication-resistant epilepsy
No Bio Available.